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1. Introduction 
An increase in the number of diabetics diagnosed at a young age has coincided with 
worldwide concerns over the fertility status of these individuals. Infertility is already a major 
health problem in both the developed and developing world, with up to one in six couples 
requiring specialist investigation or treatments in order to conceive (Agbaje et al., 2007). 
Diabetes mellitus (DM) has impacted directly and indirectly on the fertility of couples (Glenn 
et al., 2003). It may affect both male and female reproductive function at multiple levels as a 
result of its effects on the endocrine system as well as on vasculature (Sexton and Jarow, 1997). 
In a report released by the World Health Organization (WHO, 2004) indicated that the 
worldwide prevalence of diabetes was estimated to be 2.8% in 2000; furthermore, it was 
predicted to increase to 4.4% by 2030. The total number of people with diabetes was 
projected to rise from 171 million in 2000 to 366 million in 2030. It was also evident that the 
prevalence of diabetes is higher in men than in women, but there are more women with 
diabetes than men as females tend to have an increased life expectancy. These findings 
indicate that the “diabetes epidemic” will continue (Wild et al., 2004). 
When a person has diabetes or insulin resistance, it may generate a hormone imbalance 
which can trigger a domino-like effect with the remaining hormones, including estrogen, 
progesterone and testosterone levels. These hormone imbalances can cause a wide variety of 
side effects, ranging from ovarian cysts to ED and infertility. The neuroendocrine effects 
may potentiate the adverse effects of diabetes on other organ systems and, in the case of 
reproductive function, are often of major patient concern (Steger and Rabe, 1997). 
A recent study (Agbaje et al., 2007) strongly suggests that DM impairs male fertility, and the 
rising rates of diabetes may well pose a significant problem to human fertility. Male 
infertility problems may become more widespread as diabetes rates rise. Already the 
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frequency of defective spermatogenesis and accompanying decreases in sperm parameters 
such as sperm count and motility appear to be on the increase. Arguably one of the most 
compelling reasons for this phenomenon is the contributing influence of environmental and 
lifestyle factors on male reproduction.  
Lifestyle factors have had a dramatic impact on general health and the capacity to procreate. 
Cigarette smoking has been associated with adverse effects on fertility (Roth and Taylor, 
2001). Poor diet and obesity are known to be key factors in the increase in Type 2 DM which 
has led to the increased risk for infertility. Despite the lack of conclusive studies, it is evident 
that there are enough compelling reasons to believe that the future of male and female 
fertility may be actively affected and impaired by DM, lifestyle and environmental factors. 
In this review not only the effects of DM will be discussed, but also several lifestyle factors 
and occupational exposure that can impinge on the process of fertility. If and how lifestyle 
changes can positively impact on the diabetic patient’s fertility status will also be 
investigated.  
2. Lifestyle effects on fertility 
Infertility is an increasingly prevalent issue; researchers point towards changing 
environmental and lifestyle conditions as arguably the most significant causes of this 
phenomenon. Environmental and lifestyle exposure to a wide variety of factors may stress 
the male reproductive system throughout a man’s lifespan, from gestation to advanced 
adult age. Various environmental contaminants have been shown to impair sperm function 
through oxidative damage to sperm membranes. Reactive oxygen species (ROS)-mediated 
damage of sperm membranes has been reported to be responsible for impaired sperm 
motility (Archibong et al., 2008, de Lamirande and Gagnon, 1992). DNA damage, sperm 
head abnormalities (Kumar et al., 2002) as well as abnormal sperm function (Archibong et 
al., 2008) and impaired (?)sperm DNA integrity (Saleh et al., 2002) have been proven to be 
caused by the effects of environmental contaminants on the epididymis. Ultimately, male 
infertility may be the result of exposure to any combination of factors such as chemical 
toxins, smoking and alcohol abuse, poor diet and a lack of exercise and obesity, different 
types of stress, and the increasing prevalence of cellphone and ionizing radiation.  
Despite the lack of conclusive studies tracking effects of the environment and lifestyle of an 
individual throughout life, there is enough reason to believe that the environment and 
lifestyle play significant roles in the quality of male gamete production and thus male 
fertility as a whole. This argument is supported by the fact that over the last 50 years mean 
sperm counts in the general population have decreased by 50% while dramatic 
environmental and lifestyle changes have occurred during this same period.  
The prevalence of DM2 is increasing at a high rate, and the economic costs of caring for 
patients with diabetic complications are high. The increase in DM2 is closely associated with 
the epidemic of obesity in industrialized countries (Bruns and Kemnitz, 2004). Reduced 
physical activity is a contributing factor as sedentary lifestyles become more common. 
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Increased body fat, particularly in the visceral compartment, is a strong risk factor for the 
development of DM2. Elucidation of such risk factors will lead to interventions that can 
delay the onset or protect against the development of DM2 (Bruns and Kemnitz, 2004). 
Diabetes mellitus, whether due to lack of insulin secretion or resistance to insulin action, has 
adverse effects on all organ systems. 
3. Brief overview of diabetes mellitus 
Diabetes mellitus is a disorder in which blood levels of glucose are abnormally high because 
of the body’s inability to release or to respond to insulin adequately. As the oxidation or 
metabolism of these sugars from carbohydrates is the major source of energy for the human 
body, diabetes can lead to major systemic problems. 
Insulin, a hormone released from the pancreas, allows glucose to be transported into cells so 
that they can produce energy or store the glucose until it is needed. Scientists believe that an 
environmental factor (possibly a viral infection or a nutritional factor in childhood or early 
adulthood) could cause the immune system to destroy the insulin-producing cells in the 
pancreas. Some genetic predisposition is most likely needed for this to happen(Thorsby and 
Lie, 2005). 
Whatever the cause, in Type 1 diabetes more than 90 percent of the insulin-producing beta 
cells of the pancreas are permanently destroyed. This results in severe insulin deficiency and 
approximately 10 percent of people with diabetes have Type 1 diabetes. Most people who 
have Type 1 diabetes develop the disease before the age of 30; and, in order to survive, a 
person with Type 1 diabetes must regularly inject him- or herself with insulin. In Type 2 
diabetes mellitus (non-insulin-dependent diabetes), the pancreas continues to manufacture 
insulin, sometimes at even higher than normal levels. However, the body develops 
resistance to its effects, resulting in a relative insulin deficiency(Ferrannini, 1998). 
Type 2 diabetes may occur in children and adolescents but usually begins after the age of 30 
and becomes progressively more common with age: ninety percent of people with diabetes 
have Type 2 and about 15 percent of people over age 70 have Type 2 diabetes. Type 2 
diabetes occurs when the pancreas does not produce enough insulin or when the body does 
not use the insulin that is produced effectively due to the development of insulin 
resistance(Ferrannini, 1998). DM2 is associated with a sedentary lifestyle and obesity. 
Obesity is a risk factor for Type 2 diabetes; 80 to 90 percent of the people with this disease 
are obese (Wild et al., 2004). Certain racial and cultural groups are at increased risk: Blacks 
and Hispanics have a twofold to threefold increased risk of developing Type 2 diabetes. 
Type 2 diabetes also tends to run in families.  
Diabetes is one of the leading causes of death by non-communicable diseases worldwide. If 
not recognized or improperly managed, the high levels of blood glucose can slowly damage 
both the small and large blood vessels and the imbalance in hormones can impact negatively 
on the endocrine system. Not only does it result in many serious health complications such as 
heart disease, it is also a leading cause of adult blindness and kidney disease (Azadbakht et al., 
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2003, Pradeepa et al., 2002). At least 50% of all limb amputations, not due to traumatic injury, 
are due to diabetes. Diabetes is now considered to be a major cause of erectile dysfunction and 
also recognized to impact severely on reproductive capacity (Azadbakht et al., 2003).  
Type 1 and Type 2 diabetes are on the increase throughout the world, with the latter 
increasingly being described as a "modern disease" caused by lifestyle, diet and obesity. The 
reason for the increase in Type 1 diabetes is not known, but some scientists are suggesting 
that genetic factors could be involved, or that viruses could trigger the onset of the disease 
(Agbaje et al., 2007). 
4. Neuroendocrine effects of diabetes mellitus 
Diabetes mellitus in humans is often associated with hypofunction of the hypothalamic-
pituitary-thyroid axis (HPTA) (Akbar et al., 2006, Hollowell et al., 2002, Papazafiropoulou et 
al., 2010, Radaideh et al., 2004). Stress, which is associated with diabetes, may also cause 
changes in the hypothalamus-anterior-pituitary axis in these diabetics. It appears that the 
presence of sub-clinical hypothyroidism and hyperthyroidism may result from 
hypothalamus-pituitary-thyroid-axis disorders (Celani et al., 1994). Several investigators 
have demonstrated that DM affects the function of the hypothalamus. Thyroid hormones 
affect glucose metabolism via several mechanisms. Hyperthyroidism has long been 
recognized to promote hyperglycemia (Maxon et al., 1975). During hyperthyroidism, the 
half-life of insulin is reduced, most likely secondary to an increased rate of degradation and 
an enhanced release of biologically inactive insulin precursors (Dimitriadis et al., 1985, 
O'Meara et al., 1993). In addition, untreated hyperthyroidism was associated with a reduced 
C-peptide to pro-insulin ratio suggesting an underlying defect in pro-insulin processing 
(Beer et al., 1989). Another mechanism explaining the relationship between hyperthyroidism 
and hyperglycemia is the increase in the gut glucose absorption mediated by the excess 
thyroid hormones (Foss et al., 1990). When DM is accompanied by hyperthyroidism, it 
worsens hyperglycemia  through several pathological conditions caused by excessive 
thyroid hormones, such as increased glucose absorption from the intestine, decreased 
insulin secretion, decreased peripheral glucose consumption due to insulin resistance, 
increased hepatic glucose production due to activated glucose metabolism such as 
gluconeogenesis or glycogenolysis, accelerated breakdown of triglyceride in adipose tissue, 
and augmented renal clearance of insulin (Bhattacharyya and Wiles, 1999, Foss et al., 1990). 
As for hypothyroidism, glucose metabolism is affected as well via several mechanisms. A 
reduced rate of liver glucose production is observed in hypothyroidism (Okajima and Ui, 
1979) and accounts for the decrease in insulin requirement in the hypothyroid diabetic 
patient. Recurrent hypoglycemic episodes are the presenting signs for the development of 
hypothyroidism in patients with Type 1 diabetes and replacement with thyroid hormones 
reduces the fluctuations in blood glucose levels (Leong et al., 1999).  
Men with Type 2 diabetes mellitus have a higher prevalence of low testosterone levels than 
age-matched controls. In numerous cross-sectional studies, levels of testosterone in men 
have been inversely associated with several recognized risk factors for the development of 
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Type 2 diabetes, such as obesity, central adiposity (belly fat), and an elevated fasting plasma 
concentration of insulin and glucose. Several prospective studies found that low levels of 
testosterone and sex hormone–binding globulin predict the subsequent development of Type 2 
diabetes among aging men. Low plasma testosterone concentration is associated with other 
correlates of diabetes, such as cardiovascular disease and hypertension (Khaw et al., 2007). 
These neuroendocrine effects may potentiate the adverse effects of diabetes on other organ 
systems and, in the case of reproductive function, is often of major patient concern. 
5. Effects of diabetes mellitus on male fertility 
It is estimated that 15% of couples attempting to conceive are not able to do so within one 
year. Male factor infertility is present in 20%–50% of these couples, either independently or 
in conjunction with female factor infertility issues (Jarow et al., 2002, Sigman, 1997). 
Diagnosis of male infertility includes a thorough physical examination, semen analysis, 
ultrasound, and hormonal tests, if warranted. Male infertility can result from a low sperm 
count, which means the testes have produced less sperm than normal. The sperm may also 
have been unable to exit the testes, or they might not be fully functional. Male infertility 
may also result from a number of factors including: underlying health conditions, 
retrograde ejaculation, environmental pollutants and lifestyle factors. 
Certain diabetic complications can cause issues for men that contribute to infertility (Figure 
1). As DM has profound effects on the neuroendocrine axis (Steger and Rabe, 1997), in men, 
both DM1 and DM2 have long been recognized as major risk factors for sexual and 
reproductive dysfunction. This primarily includes impotence/erectile dysfunction (ED), 
ejaculatory (retrograde ejaculation) and orgasmic problems, as well as low desire (reduced 
libido), but impaired spermatogenesisis is also associated with DM (Bartak et al., 1975, 
Bhasin et al., 2007, Brown et al., 2005, Fairburn, 1981, Kolodny et al., 1974). 
 
Figure 1. The possible effect of DM and accompanying unfavorable lifestyle choices on male fertility. 
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Nerve damage or autonomic neuropathy due to diabetes can lead to retrograde ejaculation – 
where the semen goes into the bladder. Since the semen never reaches the female 
reproductive system, infertility may be an issue.  
The majority of patients with Type 2 diabetes are overweight or obese, which leads to 
decreased testosterone levels and elevated pro-inflammatory cytokines (substances 
produced in the cell). This can induce dysfunction in the blood vessel wall through the so-
called nitric oxide pathway and further explain the relationship between DM2, obesity and 
erectile dysfunction(Bhasin et al., 2007, Brown et al., 2005).  
Erectile dysfunction, or the inability to achieve an erection, is another diabetes complication 
that can lead to fertility problems in diabetic men (Brown et al., 2005, Lewis et al., 2004, 
Rosen et al., 2000). In men with DM, factors including aging, cardiovascular disease, high 
body mass index (BMI), hypercholesterolemia, smoking, and medication, in combination 
with DM-specific factors, such as duration and severity of DM and diabetic complications 
(neuropathy, nephropathy, retinopathy, and vascular damage), there is a strong correlation 
with ED (Brown et al., 2005, Lewis et al., 2004, Rosen et al., 2000). The  mechanisms for ED in 
men with DM are endothelial dysfunction, dysfunction of the nitric oxide (NO) pathways 
(down regulation of NO synthase and degeneration of nitrergic nerves), dysfunction of 
other signal transduction pathways, corporal smooth muscle degeneration, and tissue 
remodeling (Brown et al., 2005, Saenz de Tejada et al., 1989). Sexual stimulation activates the 
non-adrenergic, noncholinergic nerve and activates the neural NO synthase⁄cGMP pathway. 
The release of NO facilitates the relaxation of penile cavernosal arteries and resistance 
arterioles, which causes vasodilation, and increases blood flow to the corpus cavernosum. 
The increased blood flow stimulates the endothelium lining of the lacunar spaces of the 
corpus cavernosum to release endothelial NO from the endothelium NO synthase. These 
biochemical and physiological processes result in trabecular smooth muscle relaxation and 
expansion of the sinusoids within the corpora cavernosa, leading to penile engorgement. 
This expansion of the corpora cavernosa against the tunica albuginea results in veno-
occlusion and trapping of blood under pressure. This process is referred to as the ‘veno-
occlusive’ mechanism. Neural and endothelial NO synthases are regulated by androgens. In 
addition, the tissue histo-architecture is dependent on androgens. Thus, any perturbations 
or alterations in the neural, vascular or erectile tissue fibroelastic properties will contribute 
to ED, by altering the veno-occlusion mechanism (Traish et al., 2009). Obesity essentially 
impinges on the male reproductive system and fertility through its effects on ED and 
impaired semen parameters. Several scholars have reported a correlation between obesity 
and ED. Corona et al. (2006) presented evidence showing that 96.5% of their subjects with 
metabolic syndrome (MetS), which is characteristic of abdominal obesity, exhibited ED 
(Corona et al., 2006). A direct proportional relationship between the increasing severity of 
obesity and the severity of ED was reported. In addition, there are reported relationships 
between low serum testosterone concentrations and ED in obese patients and those with 
MetS syndrome and Type 2 diabetes mellitus. They found negative correlations between 
BMI and self-reported satisfaction with erection as well as between BMI and the percentage 
of men reporting full erection. 
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As a consequence of insulin resistance in patients with Type 2 diabetes, high circulating 
levels of insulin are present in the bloodstream. Hyperinsulinemia, which often occurs in 
obese men, has an inhibitory effect on normal spermatogenesis and can be linked to 
decreased male fertility. In a group of diabetic men, apart from semen volume (2.6 vs. 
3.3ml), semen parameters (concentration, motility and morphology) did not differ from 
those of the non-diabetic control group, but the amount of nuclear and mitochondrial DNA 
damage/fragmentation in the diabetic patients’ sperm was significantly higher (52% versus 
32%) (Agbaje et al., 2007). There were more deletions in the mitochondrial DNA of diabetic 
men's sperm cells than those of the non-diabetic men. The mitochondrial DNA deletions in the 
diabetic men's sperm cells ranged from 3 to 6 and averaged 4, while for the non-diabetic men it 
ranged from 1 to 4 and averaged 3. Deletions and fragmentation of DNA results in loss of 
genetic material which, in the case of nuclear DNA, causes infertility as the sperm is not able to 
deliver its full complement of genetic codes when fusing with the egg in order to create a 
viable embryo. The researchers concluded that diabetes is associated with increased sperm 
nuclear and mtDNA damage that may impair the reproductive capability of diabetic men.  
In addition to inducing sperm DNA damage, insulin levels  have also been shown to 
influence the levels of sex-hormone-binding globulin (SHBG), a glycoprotein that binds to 
sex hormones, specifically testosterone and estradiol, thereby inhibiting their biological 
activity as carriers. High circulating insulin levels inhibit SHBG synthesis in the liver, 
whereas weight loss has been shown to increase SHBG levels (Lima et al., 2000). In obese 
males, the decrease in SHBG means that less estrogen will be bound, resulting in more 
biologically active, free estrogen. In addition to the conversion of testosterone to estrogen in 
obese patients, the decreased ability of SHBG to sustain homeostatic levels of free 
testosterone also contributes to abnormal testosterone levels (Jensen et al., 2004). This failure 
to maintain homeostatic levels might magnify the negative feedback effect of elevated total 
estrogen levels. Even when the presence of SHBG is accounted for, an independent 
relationship between insulin resistance and testosterone production can still be 
demonstrated (Tsai et al., 2004). Therefore, the levels of SHBG might be important only as a 
marker of altered hormone profiles in obese infertile men. Reductions in semen volume and 
a higher mean incidence of nuclear DNA fragmentation is seen in diabetic men compared to 
those without Type 2 diabetes (Agbaje et al., 2007). 
Male infertility may represent perturbation in some male patients with MetS,. Obesity is a 
cardinal feature of MetS. Adverse effects of obesity on male fertility are postulated to occur 
through several mechanisms. First, peripheral conversion of testosterone to estrogen in 
excess peripheral adipose tissue may lead to secondary hypogonadism through 
hypothalamic-pituitary-gonadal axis inhibition Kasturi et al., 2008). Second, oxidative stress 
at the level of the testicular microenvironment may result in decreased spermatogenesis and 
sperm damage. Lastly, obesity accompanying DM2 is often associated with decreased 
physical activity and increased fat deposition. The accumulation of fat in the suprapubic and 
inner thigh area as well as in the scrotum may result in increased scrotal and testicular 
temperatures in severely obese men (Kasturi et al., 2008). Increased testicular temperature 
also adversely affects sperm production Kasturi et al., 2008).  
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Du Plessis and colleagues (2010) report that an increase in the size or number of adipocytes 
as a result of obesity can result in both physical changes and hormonal changes. Physical 
changes can include an increase in scrotal temperature, an increase in the incidence of sleep 
apnea, and an increase in ED. Hormonal changes might include increases in the levels of 
leptin, estrogen and insulin, and a decrease in the level of testosterone. These changes, in 
turn, contribute to oligozoospermia, azoospermia, an increase in the DNA fragmentation 
index (DFi), and a decrease in semen volume. All three categories of change contribute to 
obesity-linked male infertility (Azadbakht et al., 2003, Du Plessis et al., 2010).  
Du Plessis et al. (2010) propose that the dysregulation of the typical hypothalamic–pituitary–
gonadal axis is a consequence of obesity. The increase in estrogen and decrease in testosterone 
levels negatively affects spermatogenesis as well as regular testicular function. Inhibin B levels 
are directly related to normal spermatogenesis and thus the low levels of this protein observed 
in obese males result in abnormal spermatogenesis. The dysregulation of the axis is shown 
because, despite the low inhibin B levels observed in obese males, there is no compensatory 
increase in follicle-stimulating hormone (FSH) levels as expected. Increased estrogen levels 
further contribute to the negative feedback effect on the hypothalamus and lead to decreased 
gonodoliberin and gonadotropin release (Du Plessis et al., 2010). 
It is therefore clear that DM can be associated either directly or indirectly with several 
disorders of the male reproductive system and sexual functioning (Dinulovic and Radonjic, 
1990).  
6. Effects of diabetes mellitus on female fertility 
Women reach their peak fertility age around their early 20s, but from approximately age 35 
to 40, a woman is significantly less likely to fall pregnant. There are many factors that can 
lead to infertility. In order for a fertilized egg to grow successfully in the womb, it must be 
released by a woman’s ovaries, implanted in the lining of the uterus and survive. Infertility 
may occur if initially, the ovaries have difficulty producing eggs.. These challenges to 
fertility can be caused by lifestyle habits or underlying health problems.  
Hormonal disorders such as thyroid disease or abnormal hormone levels may also lead to 
infertility. Chronic diseases including autoimmune disorders, diabetes, cancer and 
endometriosis also make it more difficult to conceive, as can problems within or around the 
genital area, such as ovarian cysts or pelvic inflammatory disease. Eating disorders, poor 
nutrition, obesity and substance abuse may all contribute to infertility in both men and women. 
Obesity and insulin resistance are two of the most common factors that lead to infertility, 
especially female infertility. More patients are diagnosed with Polycystic Ovarian Syndrome 
(PCOS) and Dysmetabolic Syndrome X, which affects about 25% of the population. A 
Swedish study, published in 2007, associated Type 1 diabetes with reduced fertility. 
PCOS is the most common cause of female infertility (Cupisti et al., 2010). It is related to 
diabetes because of the strong feature of insulin resistance (inefficient insulin) in this subset 
of women. Many patients with PCOS have diabetes. PCOS is characterized by irregular or 
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absent menstrual periods, problems with ovulation, increased levels of androgens such as 
testosterone, and ovaries with multiple cysts (Lobo and Carmina, 2000, Pasquali et al., 2011).  
In PCOS, too much testosterone is produced and this affects the ability of the eggs to 
mature within the ovaries. Because women with PCOS develop insulin resistance, there 
are often ovulatory problems leading to irregular periods. Because of the irregularity of 
their cycles, cysts develop, which are fluid-filled cavities within the ovaries. Over time all 
of these issues make the likelihood of pregnancy begin to seem more and more distant 
(Lobo and Carmina, 2000). 
Anovulation (failure to ovulate) is the causeof about 25% of female infertility cases, with 
PCOS being the most common cause of anovulation (Cupisti et al., 2010, Goodarzi et al., 
2011, Lobo and Carmina, 2000, Walters et al., 2012). This means that PCOS could be a factor 
in about one-fifth of all infertility cases. 
Insulin is said to bind with low affinity to the luteinizing hormone receptor in the theca cells 
of the ovaries. The hyperinsulinemia or high insulin levels present in obesity, MetS, 
diabetes, or insulin resistance in general may stimulate ovarian theca cells and thus increase 
the production of hormones, including androgens. This, in turn, may inhibit normal 
ovulation because of the hampered development of ovarian follicles. In women with PCOS, 
immature follicles bunch together to form large clumps. The eggs may mature within the 
bunched follicles, but the follicles do not break open to release them. Thus, women with 
PCOS often do not have regular menstrual periods. Also, because the eggs are not released, 
most women with PCOS have difficulty falling pregnant (Goodarzi et al., 2011, Lobo and 
Carmina, 2000, Mellembakken et al., 2011, Pasquali et al., 2011, Walters et al., 2012). 
There appears to be a higher rate of miscarriage in women with PCOS. Increased levels of 
luteinizing hormone, which aids in the secretion of progesterone, may play a role. Increased 
levels of insulin and glucose may cause problems with the development of the embryo. 
Insulin resistance and late ovulation (after day 16 of the menstrual cycle) also may reduce 
egg quality, which can lead to miscarriage. 
Insulin resistance is found in up to 60% of obese women and 40% of non-obese women. Of 
the people diagnosed with Type 2 diabetes, 80% to 90% are also diagnosed as obese. This 
fact provides an interesting clue to the link between diabetes and obesity. The main diabetes 
complication (including gestational diabetes) related to pregnancy is macrosomia - or a big 
baby (higher than the 90th percentile in birth weight). Sometimes these babies are not able to 
pass through the birth canal, so there are higher incidences of caesarean sections, and 
sometimes it is necessary to induce labor early. Fetal distress can also become an issue. 
There is also an increased risk of birth defects. This condition is directly related to maternal 
diabetes problems, especially during the first few weeks when a woman may be unaware 
she is pregnant. For this reason, women with diabetes are advised to manage their insulin 
levels under control before attempting to conceive. 
Conditions associated with insulin resistance, such as obesity and DM, are often 
accompanied by increased adiposity or hyperglycemia (Vega et al., 2006). Obesity and 
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diabetes are independently associated with altered female reproductive function (Kjaer et 
al., 1992, Pettigrew and Hamilton-Fairley, 1997, Zaadstra et al., 1993). Despite the fact that 
more women suffer from DM than men, and that women share similar risks for diabetic 
complications with men, less attention has been given to sexual function in women with 
DM. The prevalence of female sexual dysfunction (FSD) and associated risk factors in 
diabetic women are less clear than in men (Bhasin et al., 2007). Sexual problems in women 
with DM may be explained by several possible mechanisms, including biological, social, and 
psychological factors (Rockliffe-Fidler and Kiemle, 2003): 1.Hyperglycemia may reduce the 
hydration of mucous membranes in the vagina, leading to decreased lubrication and 
dyspareunia; 2. Increased risk of vaginal infections increases the risk of vaginal discomfort 
and dyspareunia; 3. Vascular damage and neuropathy may result in decreased genital blood 
flow, leading to impaired genital arousal response; and 4. Psychosocial factors such as 
adjustment to the diagnosis of DM, the burden of living with a chronic disease, and 
depression may impair sexual function (Giraldi and Kristensen, 2010). 
7. Relationship between lifestyle, diabetes mellitus and infertility  
Life style habits like smoking, diet, and exercise have an impact on health  (Anderson et al., 
2010). Obesity is associated with a range of adverse health consequences and this leads to an 
increased risk of diabetes. Obesity and low weight can impact on reproductive function 
(Fedorcsak et al., 2004). There is strong evidence of the adverse effects of smoking on 
fertility. In men, smoking negatively affects sperm production, motility, and morphology, 
and is associated with an increased risk of DNA damage (Kunzle et al., 2003). There is an 
increasing body of evidence that shows that life style factors can impact on reproductive 
performance. Multivariate logistic regression reveals that smoking habits and obesity are 
significant major contributors for infertility in DM men. Bener et al. (2009) suggest that a 
lifestyle modification program that includes exercise and improved dietary habits need to be 
established to lose weight, improve fitness and improve reproductive functioning (Bener et 
al., 2009). In addition to diabetes, other co-morbid factors for infertility include 
hypertension, erectile dysfunction, varicocele, and sexually transmitted diseases.  
According to a recent review, there are few studies of obesity and male factor infertility 
amongst couples presenting for infertility treatment (Hammoud et al., 2008). However, the 
results of the studies that were reviewed generally suggest that there is a relationship 
between male infertility and an elevated BMI (Hammoud et al., 2008).  
Both exercise levels and diet impact upon weight and BMI and may therefore affect fertility. 
Despite the lack of evidence, given the known health benefits of regular exercise and a 
balanced, nutritious diet, people trying to conceive are advised to exercise moderately and 
follow a specific type of diet during the preconception period and beyond (Gardiner et al., 
2008, Moore and Davies, 2005). In the general population, female and male fertility is 
decreased by being both overweight (having a body mass index (BMI) of >25 kg ⁄m2) and 
underweight (having a BMI of <20 kg ⁄m2) (Hassan and Killick, 2004, Ramlau-Hansen et al., 
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2007). Fertility treatment is also less successful in overweight or obese women (Fedorcsak et 
al., 2004, Homan et al., 2007, Lintsen et al., 2005, Maheshwari et al., 2007, Tamer Erel and 
Senturk, 2009). There are a number of dietary factors that impact upon the human 
reproductive system. 
Heavy alcohol consumption has been shown to affect both female and male fertility 
(Grodstein et al., 1994, Hakim et al., 1998, Klonoff-Cohen et al., 2003, Windham et al., 1992). 
In men, alcohol consumption can induce testicular atrophy, impotence, reduced libido and 
cause a deterioration in sperm count (Donnelly et al., 1999, Muthusami and Chinnaswamy, 
2005, Olsen et al., 1997). In women, alcohol can alter estrogen and progesterone levels and it 
has been associated with anovulation, luteal phase dysfunction and impaired implantation 
and blastocyst development (Gill, 2000). However, it is unclear from the evidence exactly 
what level of alcohol consumption has an effect on fertility as a result of  the absence of a 
universal estimation of a ‘standard drink’ and the fact that self-reported, frequently 
retrospective data on drinking alcohol are a potential source of bias in located studies 
(Mukherjee et al., 2005).  
Although the precise effect of alcohol use on the risk of diabetes has not been clearly 
established, evidence suggests that moderate alcohol consumption is associated with a 
decreased risk of diabetes, while heavy alcohol consumption is associated with an increased 
risk. Furthermore, the ingestion of moderate amounts of alcohol by diabetics has no acute 
effect on glycemic control (Howard et al., 2004). A plausible biological mechanism by which 
moderate alcohol consumption may reduce diabetes risk is less apparent. Alcohol 
consumption was not found to be associated with changes in fasting insulin levels, a marker 
of insulin resistance, on longitudinal analysis (Moller and Jespersen, 1995). It is possible that 
moderate alcohol consumption is a marker for a healthy lifestyle that was not entirely 
accounted for by adjusting for physical activity and diet (Howard et al., 2004). Moderate 
alcohol consumption is safe and may be beneficial with regard to cardiovascular risk in 
diabetics. The effect of alcohol use on the risk of other diabetic complications, including 
retinopathy, remains uncertain (Howard et al., 2004). 
Caffeine, a mild neurostimulant, is the most popular pharmacologically active substance 
consumed worldwide. Caffeine is found in various food products and beverages, including 
coffee, tea, chocolate, cocoa products, soft and energy drinks and is also present in certain 
prescription and non-prescription medications, such as cold and influenza remedies, allergy 
and headache treatments, diet pills, diuretics and stimulants. A majority of the studies on 
caffeine and reproductive outcomes present conflicting results and should be interpreted 
with caution due to numerous methodological shortcomings, such as the following: 
inaccurate estimation of caffeine consumption; recall bias as result of retrospective 
assessment of caffeine intake, failure to allow for individual variations in caffeine 
metabolism; and inadequate control for confounding factors. Evidence suggests that 
consuming caffeine is associated with an increased time to conception, with a possible dose–
response effect (Bolumar et al., 1997, Hatch and Bracken, 1993, Stanton and Gray, 1995). 
However, when adequately considered alongside other lifestyle factors related to fertility, 
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particularly maternal age, cigarette smoking and alcohol intake, there is little evidence to 
support the detrimental effect of mild to moderate caffeine consumption on fertility (Leviton 
and Cowan, 2002, Nawrot et al., 2003). 
For reasons of ethical concern and under-reported use of recreational drugs, the evidence 
about the effect of drug on human reproductive function is sparse and research has been 
mainly conducted in the form of animal studies (Anderson et al., 2010).  
Marijuana is the most commonly used recreational drug worldwide (Battista et al., 2008). 
Marijuana contains various active components such as  cannabinoids that act in both the 
central and the peripheral nervous system and that interfere with reproductive function at 
multiple levels. Cannabinoid receptors are located in multiple sites, including reproductive 
organs such as the ovary, the uterus, the vas deferens and the testis. Acute administration of 
marijuana in women reduces luteinizing hormone levels, whereas chronic use leads to 
tolerance and unchanged hormone levels (Park et al., 2004). Cannabinoids can affect 
fertilisation, oviductal transport and foetal and placental development by dysregulating 
signalling pathways involved in reproduction and by causing hormonal dysregulation 
(Battista et al., 2008, Rossato et al., 2008). The existing human data on illicit opiates and 
reproductive function in women are equivocal and inconclusive (Battista, Pasquariello et al., 
2008). Cocaine has been shown to impair ovarian responsiveness to exogenous 
gonadotrophins in non-human primates and to adversely affect spermatogenesis in rodents 
(George et al., 1996, Thyer et al., 2001). Abnormal sexual function is common in heroin-
addicted men and persists after withdrawal of heroin (Wang et al., 1978). Deterioration of all 
the sperm parameters, predominantly abnormal motility, have been demonstrated in the 
majority of heroin-addicted males and to a lesser extent in methadone users (Ragni et al., 
1988, Ragni et al., 1985). Normal levels of serum gonadotrophins, with a significant 
elevation in prolactin and decrease in total and free testosterone levels, were reported in 
opiate-addicted men (Ragni et al., 1988, Ragni et al., 1985). The effects of cocaine and heroin 
use during pregnancy include placental disruption, pre-term delivery, low birth weight, 
neonatal mortality, neonatal withdrawal syndrome and possible long-term neurobehavioral 
effects, some of which can be associated with poor prenatal care and other substance use 
rather than purely attributed to cocaine (Hulse et al., 1998, Richardson et al., 1993). 
Couple experiencing infertility generally report that is a stressful experience (Anderson et 
al., 2010). The stress may arise from unfulfilled self-expectations, social pressure, 
undergoing evaluation and treatment, disappointment with failures and the financial costs 
associated with the whole process. Infertile women have a significantly higher prevalence of 
psychiatric disorders relative to fertile women (Chen et al., 2004). Infertile men appear to 
experience significant distress with transient episodes of impotence and sexual performance 
anxiety which may contribute to difficulties in achieving natural pregnancy (Peterson et al., 
2007, Shindel et al., 2008). Psychological stress has been considered the most common reason 
for discontinuation of fertility treatment before achieving pregnancy (Olivius et al., 2004, 
Rajkhowa et al., 2006) and pre-treatment levels of depression have been shown to be highly 
predictive of patient dropout behavior after only one IVF cycle (Smeenk et al., 2004). Besides 
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stress-related sexual dysfunction and discontinuation of treatment, stress exposure has been 
directly related to reproductive failure. The pathophysiological rationale behind this 
assumption is a complex immune-endocrine response to stress that disturbs equilibrium and 
there is evidence of a stress-associated suppression of reproductive function including the 
delaying of menarche, hypothalamic amenorrhea, ovarian dysfunction and early-onset 
perimenopause (Nakamura et al., 2008, Nepomnaschy et al., 2007).  
Despite spermatogenesis being a function of only the mature testis, environmental injury 
during maternal, perinatal and prepubertal phases can indirectly influence eventual sperm 
production in the adult male. It is believed that exposure during these phases of the 
developing testis leads to irreversible effects on spermatogenesis, while the accompanying 
effects of adulthood exposure are in all probability reversible (Dinulovic and Radonjic, 
1990). 
Evolution has caused our bodies to adapt to their environment. This connection is vital for 
reproduction as the birth of the young must coincide with plentiful food, and thus increase 
the chances of  survival (Sharpe and Franks, 2002). Although human reproduction is not 
season specific, sexual behavior and reproduction is notable all year round. Fertility is 
influenced profoundly by our environment including season and food intake (Sharpe and 
Franks, 2002). 
8. Treatments and solutions for the infertile DM patient: lifestyle 
changes 
Infertility is a global problem. It affects all socioeconomic levels, racial, ethnic and religious 
groups. Fortunately, in the majority of cases, there is a specific cause for infertility that can 
be medically resolved. In fact, only about 10% of infertility cases go unexplained. 
When a couple seeks medical help, one of the first conditions the doctor will look for is 
diabetes since the condition can cause fertility complication in both genders. In most 
instances, simple lifestyle changes like adequate nutrition and weight loss through proper 
exercise can help reverse the effects of infertility (Figure 2). Fortunately, most cases of 
infertility, which are related to diabetes, can be treated. In cases where infertility is related to 
insulin levels, correcting the imbalance is often enough to result in a successful pregnancy. 
Normal levels of blood sugar are needed to succeed in becoming pregnant. This means 
insulin, HgbA1c and hemoglobin levels as well as weight need to be monitored. For Type 1 
diabetes, insulin replacement therapy is the main treatment regime to be followed as 
prescribed by the treating physician. Furthermore, when a diabetic subject, exercises 
properly and ensuring adequate nutrition with a vitamin supplement the chances of 
conception are improved. Regular exercise helps weight loss and also aids the body in 
reducing blood glucose levels and in using insulin more efficiently. Newer approaches to 
treating infertility caused by diabetes and its complications include morbidly obese women 
undergoing bariatric or gastric bypass surgery (for weight loss). Preliminary successful 
results have been reported as diabetic women are now able to conceive as they lose weight. 
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Figure 2. Lifestyle modifications in the DM patient that can help improve fertility 
Insulin resistance can be managed with modified diet, exercise, and drugs such as 
metformin. Exercise programs, vitamin supplements and weight loss alone will better 
ovulation in one-third of patients. When Clomiphene Citrate, Metformin and Letrozole are 
used to treat the remainder of infertility patients, more than 80% of infertile couples are able 
to conceive, as long as there are no other infertility problems reported. This benevolent 
effect is due to these lifestyle changes and adequate medical intervention in due  time (Du 
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Plessis et al., 2010). Once conception is achieved, the challenge is to control blood sugar 
levels so that the pregnancy can be carried to full term. The best way to prevent miscarriage 
in women with PCOS is to normalize hormone levels to improve ovulation, and normalize 
blood glucose and androgen levels. In recent time, more doctors have been prescribing the 
drug metformin to help with this problem. 
Women who have a body mass index above 35 should lose weight before conception, and 
this should be an integral part of any fertility program’s management of all overweight and 
obese patients. Weight loss of 5-10 per cent of total body weight can achieve a 30 per cent 
reduction of visceral adiposity, an improvement in insulin sensitivity, and may help with 
restoration of ovulation. More often than not, pharmacotherapy for fertility is needed in 
addition to all these lifestyle changes and thus, the expert management of a fertility 
specialist is pivotal. 
Women with Type 2 diabetes, there have shown a higher incidence of secondary 
hypogonadotropic amenorrhea (low sex hormones leading to absence of periods), 
exacerbated by body mass index that is low and glycosylated hemoglobin (HbA1c) that is 
higher than normal. In women with diabetes mellitus desiring pregnancy, pre-pregnancy 
counseling is essential before conception is critical to diminish the risk of spontaneous 
abortion, fetal abnormalities, macrosomia (abnormally big baby), and other pregnancy 
complications. Diabetic women should aim for a HbA1clevel of below 6 %, or below 7 % if 
the risk of hypoglycemic episodes is too high, before pregnancy. 
Other lifestyle changes or tips for helping fertility in diabetics include: avoiding cigarettes 
and any drugs that may affect sperm count or may reduce sexual function; getting sufficient 
rest and reducing stress; males must prevent overheating of the testes and should avoid hot 
baths, showers, and steam rooms, while avoiding tight  underwear; and avoiding use of 
sexual lubricants, as they may affect sperm motility (Du Plessis et al., 2010). 
If fertility issues remain unresolved, intrauterine insemination (also called artificial 
insemination) and assisted reproductive technologies, such as in vitro fertilization, may be 
considered. 
With careful management of this disorder, people can live long healthy lives and the effects 
on fertility can be reduced notably.  
9. Conclusion 
Diabetes mellitus can be either directly or indirectly associated with several disorders of the 
reproductive system and sexual function. Several studies have demonstrated that diabetes 
could be prevented by weight loss, regular exercise, modification of diet, abstinence from 
smoking, and limiting the consumption of alcohol. Weight control would appear to offer the 
greatest benefit. Education of diabetes is an important first step in order to make healthy 
lifestyle choices and manage the condition effectively. 
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